People | June 03, 2022
David Kendall named Zealand Pharma CMO
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
This agreement is in addition to the $92 million filling line expansion announced in November 2021
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
Subscribe To Our Newsletter & Stay Updated
